Phase II study of carfilzomib, thalidomide, and low-dose dexamethasone as induction and consolidation in newly diagnosed, transplant eligible patients with multiple myeloma; the Carthadex trial

Ruth Wester, Ronnie van der Holt, Emelie Häcker, S Zweegman, MJ Kersten, E Vellenga, MVM Kooy, O de Weerdt, M Minnema, SJ Lonergan, A Palumbo, H Lokhorst, A. Broijl, Pieter Sonneveld

Research output: Contribution to journalArticleAcademicpeer-review

16 Citations (Scopus)
18 Downloads (Pure)
Original languageUndefined/Unknown
Pages (from-to)2265-2273
Number of pages9
Issue number11
Publication statusPublished - 2019

Research programs

  • EMC MM-02-41-03

Cite this